Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

733 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Histopathology of the broad class of carbon nanotubes and nanofibers used or produced in U.S. facilities in a murine model.
Fraser K, Hubbs A, Yanamala N, Mercer RR, Stueckle TA, Jensen J, Eye T, Battelli L, Clingerman S, Fluharty K, Dodd T, Casuccio G, Bunker K, Lersch TL, Kashon ML, Orandle M, Dahm M, Schubauer-Berigan MK, Kodali V, Erdely A. Fraser K, et al. Part Fibre Toxicol. 2021 Dec 20;18(1):47. doi: 10.1186/s12989-021-00440-z. Part Fibre Toxicol. 2021. PMID: 34923995 Free PMC article.
Physicochemical characterization and genotoxicity of the broad class of carbon nanotubes and nanofibers used or produced in U.S. facilities.
Fraser K, Kodali V, Yanamala N, Birch ME, Cena L, Casuccio G, Bunker K, Lersch TL, Evans DE, Stefaniak A, Hammer MA, Kashon ML, Boots T, Eye T, Hubczak J, Friend SA, Dahm M, Schubauer-Berigan MK, Siegrist K, Lowry D, Bauer AK, Sargent LM, Erdely A. Fraser K, et al. Part Fibre Toxicol. 2020 Dec 7;17(1):62. doi: 10.1186/s12989-020-00392-w. Part Fibre Toxicol. 2020. PMID: 33287860 Free PMC article.
Pulmonary delivery of the broad-spectrum matrix metalloproteinase inhibitor marimastat diminishes multiwalled carbon nanotube-induced circulating bioactivity without reducing pulmonary inflammation.
Young TL, Mostovenko E, Denson JL, Begay JG, Lucas SN, Herbert G, Zychowski K, Hunter R, Salazar R, Wang T, Fraser K, Erdely A, Ottens AK, Campen MJ. Young TL, et al. Among authors: fraser k. Part Fibre Toxicol. 2021 Sep 8;18(1):34. doi: 10.1186/s12989-021-00427-w. Part Fibre Toxicol. 2021. PMID: 34496918 Free PMC article.
Challenges and gaps in immunosafety evaluation of therapeutics: An IQ DruSafe survey.
Collinge M, Neff-LaFord H, Akella S, Fogal B, Fraser K, Jabbour J, Harper K, Maier CC, Malherbe L, Marshall N, Rao GK, Raman K, Skaggs H, Weber F, Fuller CL. Collinge M, et al. Among authors: fraser k. Regul Toxicol Pharmacol. 2024 Apr 18;150:105630. doi: 10.1016/j.yrtph.2024.105630. Online ahead of print. Regul Toxicol Pharmacol. 2024. PMID: 38642729
Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020-30: a modelling study.
Hartner AM, Li X, Echeverria-Londono S, Roth J, Abbas K, Auzenbergs M, de Villiers MJ, Ferrari MJ, Fraser K, Fu H, Hallett T, Hinsley W, Jit M, Karachaliou A, Moore SM, Nayagam S, Papadopoulos T, Perkins TA, Portnoy A, Minh QT, Vynnycky E, Winter AK, Burrows H, Chen C, Clapham HE, Deshpande A, Hauryski S, Huber J, Jean K, Kim C, Kim JH, Koh J, Lopman BA, Pitzer VE, Tam Y, Lambach P, Sim SY, Woodruff K, Ferguson NM, Trotter CL, Gaythorpe KAM. Hartner AM, et al. Among authors: fraser k. Lancet Glob Health. 2024 Apr;12(4):e563-e571. doi: 10.1016/S2214-109X(23)00603-4. Lancet Glob Health. 2024. PMID: 38485425 Free PMC article.
733 results